Raj Manchanda
Technik-/Wissenschafts-/F&E-Leiter bei NEUMORA THERAPEUTICS, INC.
Profil
Raj Manchanda is currently the Chief Technical Operations Officer at Neumora Therapeutics, Inc. Prior to this, he was the Chief Development Officer at Anokion US, Inc. from 2019 to 2023 and at Frequency Therapeutics, Inc. from 2016 to 2018.
Dr. Manchanda holds a doctorate degree from Yale University.
Aktive Positionen von Raj Manchanda
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2023 |
Ehemalige bekannte Positionen von Raj Manchanda
| Unternehmen | Position | Ende |
|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 01.07.2023 |
| KORRO BIO, INC. | Corporate Officer/Principal | 01.10.2018 |
Ausbildung von Raj Manchanda
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Anokion US, Inc. | |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
